VRDN logo

Viridian Therapeutics, Inc. (VRDN) Retained Earnings

Annual Retained Earnings:

-$995.86M-$269.95M(-37.19%)
December 31, 2024

Summary

  • As of today, VRDN annual retained earnings is -$995.86 million, with the most recent change of -$269.95 million (-37.19%) on December 31, 2024.
  • During the last 3 years, VRDN annual retained earnings has fallen by -$637.56 million (-177.94%).
  • VRDN annual retained earnings is now -14897.85% below its all-time high of -$6.64 million, reached on December 31, 2014.

Performance

VRDN Retained Earnings Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherVRDNbalance sheet metrics

Quarterly Retained Earnings:

-$1.18B-$100.73M(-9.30%)
June 30, 2025

Summary

  • As of today, VRDN quarterly retained earnings is -$1.18 billion, with the most recent change of -$100.73 million (-9.30%) on June 30, 2025.
  • Over the past year, VRDN quarterly retained earnings has dropped by -$344.06 million (-40.99%).
  • VRDN quarterly retained earnings is now -17723.86% below its all-time high of -$6.64 million, reached on December 31, 2014.

Performance

VRDN Quarterly Retained Earnings Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherVRDNbalance sheet metrics

Retained Earnings Formula

Retained Earnings = Retained Earnings (start of the period) + Net Income − Dividends Paid

VRDN Retained Earnings Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1Y1 Year-37.2%-41.0%
3Y3 Years-177.9%-186.2%
5Y5 Years-492.2%-548.0%

VRDN Retained Earnings Highs & Lows

PeriodPeriodAnnual vs HighAnnual vs HighAnnual vs LowAnnual vs LowQuarter. vs HighQuarter. vs HighQuarter. vs LowQuarter. vs Low
3Y3-Year-177.9%at low-142.4%at low
5Y5-Year-492.2%at low-529.0%at low
All-TimeAll-Time>-9999.0%at low>-9999.0%at low

VRDN Retained Earnings History

DateAnnualQuarterly
Jun 2025
-
-$1.18B(-9.3%)
Mar 2025
-
-$1.08B(-8.7%)
Dec 2024
-$995.86M(-37.2%)
-$995.86M(-8.7%)
Sep 2024
-
-$916.13M(-9.1%)
Jun 2024
-
-$839.44M(-8.4%)
Mar 2024
-
-$774.45M(-6.7%)
Dec 2023
-$725.91M(-48.7%)
-$725.91M(-10.1%)
Sep 2023
-
-$659.05M(-7.8%)
Jun 2023
-
-$611.39M(-9.9%)
Mar 2023
-
-$556.33M(-14.0%)
Dec 2022
-$488.17M(-36.2%)
-$488.17M(-18.1%)
Jun 2022
-
-$413.48M(-7.7%)
Mar 2022
-
-$383.99M(-7.2%)
Dec 2021
-$358.30M(-28.5%)
-$358.30M(-8.8%)
Sep 2021
-
-$329.35M(-4.5%)
Jun 2021
-
-$315.31M(-6.0%)
Mar 2021
-
-$297.35M(-6.6%)
Dec 2020
-$278.89M(-65.8%)
-$278.89M(-48.2%)
Sep 2020
-
-$188.15M(-3.0%)
Jun 2020
-
-$182.65M(-3.7%)
Mar 2020
-
-$176.22M(-4.8%)
Dec 2019
-$168.17M
-$168.17M(-6.4%)
Sep 2019
-
-$158.05M(-7.6%)
DateAnnualQuarterly
Jun 2019
-
-$146.82M(-6.4%)
Mar 2019
-
-$137.93M(-9.2%)
Dec 2018
-$126.30M(-34.9%)
-$126.30M(-8.9%)
Sep 2018
-
-$115.98M(-8.4%)
Jun 2018
-
-$106.97M(-8.9%)
Mar 2018
-
-$98.25M(-5.0%)
Dec 2017
-$93.59M(-205.4%)
-$93.59M(-7.3%)
Sep 2017
-
-$87.21M(-7.2%)
Jun 2017
-
-$81.37M(-9.9%)
Mar 2017
-
-$74.06M(-10.4%)
Dec 2016
-$30.64M(-70.5%)
-$67.08M(-167.5%)
Sep 2016
-
-$25.07M(-7.9%)
Jun 2016
-
-$23.23M(-12.1%)
Mar 2016
-
-$20.73M(-15.3%)
Dec 2015
-$17.97M(-170.6%)
-$17.97M(-19.9%)
Sep 2015
-
-$14.99M(-26.6%)
Jun 2015
-
-$11.84M(-27.6%)
Mar 2015
-
-$9.27M(-39.7%)
Dec 2014
-$6.64M(+72.2%)
-$6.64M(+78.9%)
Sep 2014
-
-$31.52M(-5.5%)
Jun 2014
-
-$29.88M(-25.1%)
Dec 2013
-$23.89M(-11.4%)
-$23.89M
Dec 2012
-$21.44M
-

FAQ

  • What is Viridian Therapeutics, Inc. annual retained earnings?
  • What is the all-time high annual retained earnings for Viridian Therapeutics, Inc.?
  • What is Viridian Therapeutics, Inc. annual retained earnings year-on-year change?
  • What is Viridian Therapeutics, Inc. quarterly retained earnings?
  • What is the all-time high quarterly retained earnings for Viridian Therapeutics, Inc.?
  • What is Viridian Therapeutics, Inc. quarterly retained earnings year-on-year change?

What is Viridian Therapeutics, Inc. annual retained earnings?

The current annual retained earnings of VRDN is -$995.86M

What is the all-time high annual retained earnings for Viridian Therapeutics, Inc.?

Viridian Therapeutics, Inc. all-time high annual retained earnings is -$6.64M

What is Viridian Therapeutics, Inc. annual retained earnings year-on-year change?

Over the past year, VRDN annual retained earnings has changed by -$269.95M (-37.19%)

What is Viridian Therapeutics, Inc. quarterly retained earnings?

The current quarterly retained earnings of VRDN is -$1.18B

What is the all-time high quarterly retained earnings for Viridian Therapeutics, Inc.?

Viridian Therapeutics, Inc. all-time high quarterly retained earnings is -$6.64M

What is Viridian Therapeutics, Inc. quarterly retained earnings year-on-year change?

Over the past year, VRDN quarterly retained earnings has changed by -$344.06M (-40.99%)
On this page